by TractManager | Jul 13, 2021 | Health Technology Assessment
Focus of the Report: The use of Zilretta (triamcinolone acetonide extended-release injectable suspension) for the treatment of pain associated with knee osteoarthritis (KOA).Technology Description: Zilretta (Flexion Therapeutics Inc.) is an extended-release...
by TractManager | Jul 8, 2021 | News
On July 7, 2021, the Food and Drug Administration (FDA) posted a modified label for Aduhelm (aducanumab; Biogen Inc.) clarifying the population in which treatment should be initiated.Aduhelm is an amyloid beta-directed antibody that was initially granted accelerated...
by TractManager | Jul 7, 2021 | Clinical Utility Evaluation
This report evaluates the clinical utility of genetic testing to detect hereditary cancer 1) high risk and 2) moderate risk gene variants in women with new diagnoses of breast cancer (BC), who are not preselected for other risk factors, to improve disease...
by TractManager | Jul 7, 2021 | Clinical Utility Evaluation
This report evaluates the clinical utility of cell-free DNA (cfDNA) (formerly NIPS, NIPT) screening for fetal trisomy 21, 18, and 13 in women with twin pregnancies.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Jul 1, 2021 | News
On June 30, 2021, the Food and Drug Administration (FDA) announced a recall of certain Philips Respironics ventilators, BiPAP, and CPAP machines due to potential health risks. These devices are used to provide breathing assistance. The polyester-based...
Recent Comments